Market Place
Sourcing Support
All News #Library
Quality
FDA Rejects Eylea HD For Ongoing Manufacturing Issues
28 Oct 2025 //
FIERCE PHARMA
Novo Plant Issues May Mean Delays For Regeneron, Scholar Rock
13 Oct 2025 //
FIERCE PHARMA
Issues at Novo Nordisk`s Indiana site trip up Regeneron again
01 Aug 2025 //
FIERCE PHARMA
US FDA declines to approve Regeneron`s blood cancer therapy
21 Aug 2024 //
REUTERS
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma
26 Mar 2024 //
BIOSPACE
FDA deals blow to Sanofi, Regeneron’s approval efforts for Dupixent in hives
21 Oct 2023 //
PRESS RELEASE
FDA Issues CRL for Aflibercept 8mg BLA Solely Due to Ongoing Review Inspection
27 Jun 2023 //
GLOBENEWSWIRE
FDA requires new health warnings for cigarette packages and advertisements
17 Mar 2020 //
PR NEWSWIRE
Pfizer recalls migraine med because of bacterial contamination
15 Aug 2019 //
FIERCE PHARMA
FDA Action Alert: Regeneron, Celgene and Aerie
11 Mar 2019 //
BIOSPACE
Regeneron gets CRL as it shoots for approval of Eylea in NPDR
26 Oct 2018 //
FIERCE PHARMA
Osteoarthritis: FDA Drafts Guidance on Developing Drugs, Devices, Biologics
22 Aug 2018 //
RAPS
FDA Calls Regeneron (REGN)`s Evinacumab a Breakthrough
06 Apr 2017 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.